All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

/images/Cortellis_Flagship_Logo_TM_RGB_Color.png
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Artificial intelligence
    • Coronavirus
    • Diagnosing and tracking COVID-19
    • Drugs to Watch 2020
    • The next pandemic
    • Premium reports
      • BioWorld Financings Reports
      • Disease Forecast Reports

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, March 3, 2021
Home » Blogs » BioWorld Perspectives » @ASCO2011: Genomics Era of Cancer has Arrived – Like a Tsunami

BioWorld Perspectives
BioWorld Perspectives RSS FeedRSS

BioWorld

@ASCO2011: Genomics Era of Cancer has Arrived – Like a Tsunami

June 4, 2011
By Anette Breindl
No Comments

CHICAGO ‑ As a scientist by training, I tend to look with unbridled optimism at technological advances. So it was striking to me to see how those that are expected to do something useful with such advances sometimes have a more nuanced take on them.

Genomic technologies have led to a “tsunami of information,” outgoing ASCO president George Sledge told the audience in his plenary lecture. And it is a tsunami that the current clinical trials system, let alone the practicing oncologist, is in many ways unprepared for.

Sledge is no Luddite. In fact, he spent much of his talk describing how such technologies will be necessary to make a dent into cancers that are driven by more complex cellular underpinnings than one dominant mutation such as bcr-abl.

And he is hardly alone in pointing out that the genomics era of cancer has arrived.

But his take on the near-term effects of the $1,000 genome was nuanced: “When data are that cheap . . . Things will get very, very complicated,” he told the audience. “What happens when a few years from now a patient walks into a doctor’s office and hands him a memory stick with his genome?”

His take on modern technology was shared by the MD Anderson president, who spoke in an education session on personalized medicine. The technology-driven push of a firehose of information, he said, is “advancing the science of medicine, but complicating the practice of medicine.”

You must login or register in order to post a comment.

Report Abusive Comment

Popular Stories

  • Free access to BioWorld coronavirus articles

    BioWorld

    The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus outbreak. Note that we have added three critical tables which are...

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 2.
  • Gloved hand places sample tubes in PCR system

    COVID-19 test makers are adapting for variants

    BioWorld MedTech
    As COVID-19 variants have emerged, so have questions about the effectiveness of tests for infection. While the risk of mutations significantly limiting their...
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech's briefs for March 2.
  • Celltrion-Regkirona-2-9

    Celltrion wins first conditional Korean approval for COVID-19 antibody Regkirona

    BioWorld
    HONG KONG – Celltrion Inc. has received conditional marketing authorization from the Ministry of Food and Drug Safety (MFDS) for its anti-COVID-19 monoclonal...
cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • About
    • Archives
    • Today's news
    • Search BioWorld Science
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
A Clarivate Analytic solution. Link to Clarivate website.
Follow Us

Copyright ©2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing